An analyst thinks he has cracked the code on why highflying Eli Lilly missed two quarters of Wall Street projections.
With GLP-1-related drugs having won the race to weight loss approval, attention at many obesity-focused biopharmas has turned ...
An investigational drug from Veru helped preserve lean mass in patients taking Wegovy, though some experts raised questions ...
One of Novo Nordisk's next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their ...
Ozempic and Wegovy are being linked to surprising effects on overall health. A new study finds these drugs may improve heart ...
One of Novo Nordisk's next-generation obesity shots to follow up on its success with Wegovy helped patients lose 22% of their ...